MedTrace Logo

Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions

NCT00851162 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2012-11-28

No results posted yet for this study

Summary

The purpose of this study is to determine whether using mesenchymal stem cells will heal benign bone lesion defects faster than demineralized bone matrix

Conditions

  • Bone Neoplasms

Interventions

BIOLOGICAL

Trinity multipotent stem cells

Enough to fill voids which vary in size

BIOLOGICAL

Demineralized bone matrix(DBM)

Enough DBM to fill a bone void defect

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Shervin Oskouei, MD · Emory University Department of Orthopaedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00851162 on ClinicalTrials.gov